Recent Finacing
Recent Raise
Stuart Therapeutics develops PolyCol™ synthesized peptides that repair extracellular matrix collagen for topical ophthalmic therapies, including ST-100 for dry eye and candidates for glaucoma and age-related macular degeneration.
